查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541258

2024-2032 年按治疗类别、类型、配销通路和地区分類的抗高血压药物市场报告

Antihypertensive Drugs Market Report by Therapeutic Class, Type, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2023年全球抗高血压药物IMARC Group规模达297亿美元。高血压盛行率的增加、心血管疾病患者数量的增加以及临床研究数量的增加是推动市场发展的一些关键因素。

抗高血压药物用于治疗高血压，血液对动脉壁的压力变大，并可能增加心臟病、中风和其他健康问题的风险。它们通常包括利尿剂、β-阻断剂、钙通道阻断剂、血管紧张素转换酶(ACE)抑制剂和血管扩张剂。它们的作用是放鬆血管、减少血管中的液体量以及减少导致血管收缩的荷尔蒙量。它们还能减慢心跳，维持健康的收缩压，提高预期寿命，并最大限度地降低过早死亡的风险。目前，主要参与者正在推出咪唑啉、莫那皮尔和中性内肽酶抑制剂来扩大其产品组合。

抗高血压药物市场趋势：

高血压和高血压在个人中的盛行率激增是推动全球抗高血压药物需求的主要因素之一。此外，容易患这些疾病的老年人口不断增加，正在对市场产生积极影响。此外，由于久坐的生活方式、不健康的饮食模式、高压力水平、糖尿病和肥胖，导致心血管疾病（CVD）患者数量不断增加，有利于市场的成长。除此之外，许多国家的管理机构正在发起运动，以提高人们对高血压疾病、其症状、诊断和治疗的认识。再加上开发高血压新疗法的临床研究和试验数量不断增加，正在加强市场的成长。此外，由于医疗费用不断增加，越来越多地使用非处方药（OTC）来治疗血压相关疾病，这为市场创造了积极的前景。除此之外，根据消费者所需剂量提供抗高血压药物的线上零售平台数量有所增加。这加上製药和电子商务行业的显着成长，正在推动市场的成长。此外，越来越多地采用为高血压治疗提供经济援助并最大限度地减少医疗费用的健康保险政策正在推动市场的成长。

本报告回答的关键问题：

  • 迄今为止，全球抗高血压药物市场表现如何，未来几年将如何表现？
  • 全球抗高血压药物市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球抗高血压药物市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的抗高血压药物市场？
  • 基于治疗类别的市场区隔是什么？
  • 抗高血压药物市场上最具吸引力的治疗类别是什么？
  • 依类型划分市场是怎么样的？
  • 降血压药市场上哪一类最具吸引力？
  • 基于配销通路的市场区隔是什么？
  • 降血压药市场上最具吸引力的配销通路是哪一个？
  • 全球降血压药市场竞争格局如何？
  • 全球抗高血压药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球抗高血压药物市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依治疗类别

  • 利尿剂
    • 市场趋势
    • 市场预测
  • ACE抑制剂
    • 市场趋势
    • 市场预测
  • 钙通道阻断剂
    • 市场趋势
    • 市场预测
  • β-肾上腺素阻断剂
    • 市场趋势
    • 市场预测
  • 血管扩张剂
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按类型

  • 原发性高血压
    • 市场趋势
    • 市场预测
  • 继发性高血压
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 零售药房
    • 市场趋势
    • 市场预测
  • 医院药房
    • 市场趋势
    • 市场预测
  • 电子商务
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AstraZeneca
    • Boehringer Ingelheim International GmbH
    • Daiichi Sankyo Company Limited
    • Johnson & Johnson Services Inc.
    • Lupin Pharmaceuticals Inc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Sun Pharmaceutical Industries Ltd.
Product Code: SR112024A4190

The global antihypertensive drugs market size reached US$ 29.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.7% during 2024-2032. The increasing prevalence of hypertension, rising number of patients suffering from CVDs, and the growing number of clinical studies represent some of the key factors driving the market.

Antihypertensive drugs are utilized to treat hypertension wherein the force of blood against the walls of the arteries becomes high and can increase the risk of heart disease, stroke, and other health problems. They generally comprise diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and vasodilators. They work by relaxing the blood vessels, reducing the amount of fluid in the blood vessels, and decreasing the amount of hormones that cause blood vessels to constrict. They also slow down the heartbeat, maintain a healthy systolic BP, improve life expectancy, and minimize the risk of premature death. At present, key players are introducing imidazolines, monatepil, and neutral endopeptidase inhibitors to expand their product portfolio.

Antihypertensive Drugs Market Trends:

The surging prevalence of hypertension and high BP among individuals represents one of the major factors driving the demand for antihypertensive drugs around the world. Moreover, the growing geriatric population that is susceptible to developing these medical disorders is influencing the market positively. In addition, the increasing number of patients suffering from cardiovascular diseases (CVDs) on account of sedentary lifestyles, unhealthy dietary patterns, high-stress levels, diabetes, and obesity among the masses is favoring the growth of the market. Apart from this, governing agencies of numerous countries are initiating campaigns to spread awareness about the hypertension disorder, its symptoms, diagnosis, and treatment. This, coupled with the rising number of clinical studies and trials to develop new treatments for hypertension, is strengthening the growth of the market. Furthermore, the growing usage of over the counter (OTC) drugs to treat BP-related diseases on account of expanding healthcare costs is creating a positive outlook for the market. Besides this, there is a rise in the number of online retail platforms that offer antihypertensive drugs according to the dosage needed by the consumer. This, along with significant growth in the pharmaceutical and e-commerce industries, is propelling the growth of the market. Additionally, the increasing adoption of health insurance policies that provide financial assistance for hypertension treatment and minimize healthcare expenses is impelling the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antihypertensive drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapeutic class, type and distribution channel.

Therapeutic Class Insights:

Diuretics

ACE Inhibitors

Calcium Channel Blockers

Beta-adrenergic Blockers

Vasodilators

Others

The report has provided a detailed breakup and analysis of the antihypertensive drugs market based on the therapeutic class. This includes diuretics, ACE inhibitors, calcium channel blockers, beta-adrenergic blockers, vasodilators, and others. According to the report, calcium channel blockers represented the largest segment.

Type Insights:

Primary Hypertension

Secondary Hypertension

A detailed breakup and analysis of the antihypertensive drugs market based on the type has also been provided in the report. This includes primary hypertension and secondary hypertension. According to the report, primary hypertension accounted for the largest market share.

Distribution Channel Insights:

Retail Pharmacy

Hospital Pharmacy

E-Commerce

The report has provided a detailed breakup and analysis of the antihypertensive drugs market based on the distribution channel. This includes retail pharmacy, hospital pharmacy, and e-commerce. According to the report, hospital pharmacy represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for antihypertensive drugs. Some of the factors driving the North America antihypertensive drugs market included expansion of online pharmacies, government initiatives, product innovation, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global antihypertensive drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AstraZeneca, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global antihypertensive drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global antihypertensive drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global antihypertensive drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive antihypertensive drugs market?
  • What is the breakup of the market based on the therapeutic class?
  • Which is the most attractive therapeutic class in the antihypertensive drugs market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the antihypertensive drugs market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the antihypertensive drugs market?
  • What is the competitive structure of the global antihypertensive drugs market?
  • Who are the key players/companies in the global antihypertensive drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Antihypertensive Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutic Class

  • 6.1 Diuretics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 ACE Inhibitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Calcium Channel Blockers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Beta-adrenergic Blockers
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vasodilators
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Primary Hypertension
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Secondary Hypertension
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 E-Commerce
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AstraZeneca
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Daiichi Sankyo Company Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson Services Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Lupin Pharmaceuticals Inc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sanofi
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sun Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Antihypertensive Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Antihypertensive Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Antihypertensive Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Antihypertensive Drugs Market: Breakup by Therapeutic Class (in %), 2023
  • Figure 5: Global: Antihypertensive Drugs Market: Breakup by Type (in %), 2023
  • Figure 6: Global: Antihypertensive Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Antihypertensive Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Antihypertensive Drugs (Diuretics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Antihypertensive Drugs (Diuretics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Antihypertensive Drugs (ACE Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Antihypertensive Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Antihypertensive Drugs (Vasodilators) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Antihypertensive Drugs (Vasodilators) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Antihypertensive Drugs (Primary Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Antihypertensive Drugs (Primary Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Antihypertensive Drugs (Secondary Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Antihypertensive Drugs (Secondary Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Antihypertensive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Antihypertensive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Antihypertensive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Antihypertensive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Antihypertensive Drugs (E-Commerce) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Antihypertensive Drugs (E-Commerce) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Antihypertensive Drugs Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Antihypertensive Drugs Industry: SWOT Analysis
  • Figure 80: Global: Antihypertensive Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Antihypertensive Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antihypertensive Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Antihypertensive Drugs Market Forecast: Breakup by Therapeutic Class (in Million US$), 2024-2032
  • Table 3: Global: Antihypertensive Drugs Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 4: Global: Antihypertensive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Antihypertensive Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Antihypertensive Drugs Market: Competitive Structure
  • Table 7: Global: Antihypertensive Drugs Market: Key Players